Multivalent Chlorotoxin Chimeric Antigen Receptors
Application
US20260078529A1
Kind: A1
Mar 19, 2026
Inventors
Lei DING, Lawrence S. LAMB, JR.
Abstract
Described are γδ T-cells that express a multivalent CLTX-CAR and also express a survival factor, a population of the γδ T-cells that express a multivalent CLTX-CAR and the survival factor, pharmaceutical compositions thereof, and methods of treating cancer or a tumor in a subject comprising administering to a subject an effective amount of the multivalent CLTX-CAR γδ T-cells and co-administering a chemotherapeutic agent, e.g., the chemotherapeutic agent to which the survival factor confers resistance.
CPC Classifications
C40B 40/02
A61K 40/11
A61K 40/31
A61K 40/429
C07K 14/43522
C07K 14/70521
A61K 2239/47
C07K 2317/21
C07K 2317/24
C07K 2317/622
Filing Date
2025-04-09
Application No.
19174283